ENIBARCIMAB
UNII K2IB8MBP1A

Substance Identification & Data

This profile provides standardized clinical and technical data for Enibarcimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K2IB8MBP1A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2305638-98-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

K2IB8MBP1A

CAS Registry Number

2305638-98-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ENIBARCIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175779

National Cancer Institute reference terminology for clinical and research data.

INN ID

11412

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enibarcimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENIBARCIMAB

Common Names & Synonyms

ADRECIZUMAB

ENIBARCIMAB [INN]

ENIBARCIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN ADRENOMEDULLIN) (HUMAN-MUS MUSCULUS MONOCLONAL HAM8101 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HAM8101 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ADM (ADRENOMEDULLIN)), MONOCLONAL ANTIBODY